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Calcium ions act as ubiquitous second messengers in 
cells and trigger a multitude of cellular processes including 
secretion, contraction, metabolism, cell division, and cell 
growth. Calcium binding proteins are intracellular receptor 
molecules and couple changes in intracellular calcium levels 
with alterations in cell functions [1].
The S100 protein family represents one of the largest 
subfamilies of the EF-hand calcium-binding proteins, 
approximately 10,000 Da in size, with at least 19 different 
members with 50% homology in amino acid sequences [2]. 
Each member of the family exhibits a unique pattern of 
expression with some cells expressing multiple members of 
the family [1]. S100 proteins interact with other proteins to 
modulate various biologic functions and are thus related to 
various diseases, many of which involve inflammation, innate 
immunity, tissue damage, wound healing, stress response, 
cell motility, proliferation, and differentiation [3].
Although numerous studies have reported the physical 
properties, functions, and expression of some of these 
proteins (for example, S100 A1, S100 A8, S100 A9, and S100 
B), for others little is known (for example, S100 A3 and S100 
A5) [1]. Increased expression of different S100 proteins was 
identified in many cancers. For example, increased levels of 
S100 proteins were found in melanomas and acute leukemic 
change of myelocytes, increased levels of S100 B were 
reported in thyroid carcinoma, and increased levels of S100 
A1 were reported in renal carcinoma [4]. Furthermore, many 
studies have reported that S100 proteins are implicated in 
regulating tumor cell proliferation and metastasis and are 
indirectly related to the prognosis of the disease; the lower 
the concentration of S100, the longer patients survive [1].
An increased level in S100 protein expression has also 
been found in different parts of the ocular system [5]. Several 
studies reported the expression of S100 proteins on the ocular 
surface in pathological inflammatory and non-inflammatory 
conditions. For example, increased expression of S100 A2 [6] 
and A4 has been found in the keratoconus corneal epithelium 
[7]. S100 A4, S100 A6, S100 A8, S100 A9, and S100 A13 were 
upregulated in corneal neovascularization murine models 
[8]. S100 A4 was reported to be overexpressed in keratocyte 
phenotypes that appear in stromal tissue of corneas recov-
ering from damage, and it was hypothesized that S100 A4 is 
involved in the corneal wound healing process [9].
An increased level of S100 A6, A8, and A9 has also 
been identified in pterygium [10] compared with normal 
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Purpose: To study the expression of S100 A and B family proteins in normal human limbus and to analyze modification 
of the expression in inflammatory conditions.
Methods: The total expression of members of the S100 family and the expression of A4, A8, A9, and B individually 
were evaluated in nine normal human corneal limbi, collected from cadaver healthy donors, in particular in the limbal 
epithelial crypts (LECs), and in five inflamed limbi obtained from enucleated eyes. S100 protein distribution was deter-
mined with immunohistochemistry staining analysis.
Results: Cytoplasmic expression of total S100 proteins was observed in 100% of LECs; in contrast, the inflamed tissues 
were completely negative, and faint positivity was observed in only one case. Moreover, cytoplasmic expression of S100 
A4 and A9 was uniformly found in the entire LECs in all samples analyzed, while S100 A8 positivity was observed in 
only 44.4% of cases and only in the cells localized in the central area of the LEC. Positivity for S100 B was not observed 
in all samples analyzed.
Conclusions: As reported in the literature, normal limbal epithelial cells show strong expression of S100 proteins. A 
novel finding of this study was the expression for the limbal epithelial crypts. In particular, S100 A4 and A9, which are 
normally involved in regulating a wide range of biologic effects, including cell motility, survival, and differentiation, are 
the most expressed members in healthy limbal crypts. In inflamed tissues, expression of S100 proteins was dramatically 
decreased. S100 proteins, and in particular S100 A4 and S100 A9, can be useful as markers of early changes in stem cell 
niches due to inflammation.
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conjunctiva and of S100 A8 and A9 in tear samples of patients 
with pterygium compared to controls [11]. An abnormal level 
of S100 has also been detected in some rare ocular surface 
tumors [12] in the tears of patients with dry eye [13] and in 
the tear film of contact lens wearers (in particular S100 A8) 
[14]. Thus, numerous studies support the hypothesis of the 
involvement of S100 A proteins in inflammatory processes 
of the ocular surface.
The corneal epithelium is continuously renewed by a 
pool of cells with proliferative potential that reside in the 
basal epithelial layer of the human corneoscleral limbus in 
specific anatomic structures called limbal epithelial crypts 
(LECs) [15]. A recent study by Jing and colleagues reported 
the expression of S100 A proteins in normal corneal limbal 
epithelial cells and found it to be similar to that in normal 
skin [16].
The goal of our study was to investigate the presence 
of the S100 protein family and to quantify the levels of A4, 
A8, A9, and B in normal human LECs. We also evaluated 
modification of the expression of these proteins in inflam-
matory conditions.
METHODS
Healthy and pathological samples collection: This study 
adhered to the tenets of the Declaration of Helsinki. The 
protocol was approved by our local ethical committee. Nine 
human eye bank corneal buttons with scleral rims, not suit-
able for transplantation (mean age 69.6±9.8 years, ages ranged 
from 52 to 80), were included in the study. The average death 
to enucleation time was 8 h (range from 4 h to 10 h). The 
mean storage (Eusol-C, Alchimia Srl, Ponte San Nicolò, Italy) 
time (between eye bank procedures and fixation) was 26 h 
(range 20 h to 48 h). No evidence of disease, desiccation, or 
damage was noted. All tissue was fixed in 4% formalin (Bio 
Optica, Milan, Italy).
In addition, five limbus samples were collected from 
pathological corneosclera (mean age 69.4±9.6 years, age 
ranged from 59 to 85) at the time of the surgical procedures 
of enucleation of the eye due to uncontrolled infectious 
endophthalmitis affecting the cornea and the ocular surface. 
Tissues were fixed in formalin. The etiology of endo-
phthalmitis was originally related to corneal infection and 
included Stenotrophomonas maltophilia, Aspergillus flavus, 
Candida albicans, Pseudomonas aeruginosa, and one case 
of Herpes simplex virus necrotizing keratitis with cornea 
perforation and subsequent microbial unidentified superin-
fection. All pathological eyes presented variable degrees of 
limbal inflammation. Inflammatory cell phenotypes were 
determined by the presence of macrophages, granulocytes, 
and lymphocytes, as assessed with immunohistochemistry 
staining (data not shown).
Healthy donors were serially cut with a microtome (Leica 
Microsystems GmbH, Wetzlar, Germany), and monitored for 
the presence of LEC by staining of every 10th to 15th section 
with hematoxylin and eosin. When a region containing the 
LEC was identified, the adjacent sections were collected for 
immunohistochemistry staining. In addition, a p63 stain was 
performed to confirm the presence of LEC (supplementary 
data).
Histological staining analysis: Immunohistochemistry 
analysis was performed on sections in which we observed the 
presence of LECs with hematoxylin and eosin staining and 
for all inflamed samples. Sections were stained in triplicate 
for the following antibodies: S100 (1:400, Dako, Glostrup, 
Denmark), S100 A4 (1:400, Abcam, Cambridge, England), 
S100 A8 (1:500, Sigma-Aldrich, St. Louis, MO), S100 A9 
(1:100, Abcam), and S100 B (1:300, Abcam). Formalin-fixed 
tissues were deparaffinized and pretreated with microwave 
antigen retrieval using sodium citrate buffer for pH 6 (for 
S100) or EDTA for pH 9 (required for S100 A4, S100 A8, and 
S100 B). For all these antigens, the EnVision Rabbit system 
(Dako) was used before diaminobenzidine tetrahydrochloride 
(Dako) incubation. A negative control was performed for each 
antigen using the specific isotype control. All slides for the 
same antigen were stained together, with the same required 
antigen retrieval buffer and antibody dilution. The slides were 
examined in a double-blind fashion, and digital images of 
representative areas were taken.
RESULTS
Expression of total S100 proteins in healthy and inflamed 
human limbus: Expression of S100 A and B was evaluated 
in healthy (nine samples) and inflamed (five samples) human 
limbus (Table 1). No staining was observed in a specific 
isotype control (results not shown). Strong cytoplasmic 
expression was observed in all LECs of healthy corneas 
(Figure 1A), while negative (4/5 samples, 80%) or a few 
positive cells were observed in inflamed limbus (1/5 samples 
20%; Figure 1B).
Expression of S100 protein members in normal human 
limbus: Based on the strong S100 expression observed in 
healthy LECs, the individual localization of S100 A4, S100 
A8, S100 A9, and S100 B proteins was analyzed. Strong S100 
A4 staining was consistently observed in all samples (9/9 
samples, 100%; Table 2). Cytoplasmic S100 A4 positivity was 
observed in the entire LEC (Figure 2A). Sporadic cytoplasmic 
positivity for S100 A8 antigen was observed in the center of 
the LEC (Figure 2B). Limbal crypts with S100 A8 positive 
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cells were observed in 44.4% (4/9 samples) of analyzed cases 
(Table 2). Similarly to S100 A4, strong positivity for S100 A9 
was found in all samples (Table 2 and Figure 2C). The expres-
sion of S100 B was not observed (Table 2 and Figure 2D).
DISCUSSION
This study reports the expression of the S100 family proteins 
and the individual expression of S100 A4, A8, A9, and B 
members in normal human limbus (in particular in the LECs) 
and in eyes with inflamed limbus. LECs were first identified 
by Tseng [15] and then described by Dua et al. [17].
Recent studies have linked S100 positivity in the ocular 
surface tissue in proliferative, pathological inflammatory 
and non-inflammatory conditions [5]. Furthermore, a recent 
study by Jing and colleagues demonstrated differential 
expression and cellular distribution of multiple S100 A genes 
and proteins in normal corneal-limbal cells, suggesting that 
selective S100 proteins were involved in corneal epithelial 
cell proliferation and differentiation under normal and patho-
logical conditions [16]. In our study, we tested four S100 
members and in particular the S100 members that had been 
Table 1. ToTal S100 expreSSion in differenT human 
healThy and inflamed limbuS SampleS.
Tissues S100 positivity
Healthy limbus 1 ++
Healthy limbus 2 ++
Healthy limbus 3 ++
Healthy limbus 4 ++
Healthy limbus 5 ++
Healthy limbus 6 ++
Healthy limbus 7 ++
Healthy limbus 8 ++
Healthy limbus 9 ++
Inflamed limbus 1 -
Inflamed limbus 2 -
Inflamed limbus 3 -/+
Inflamed limbus 4 -
Inflamed limbus 5 -
++: strong posititvity -/+: few positive cells -: no positive cells
Figure 1. Immunohistochemical 
staining of total S100 in human 
healthy and inflamed limbal stem 
cell niche: The expression of S100 
was localized in the cytoplasm 
of limbal cell niche (A) and was 
almost absent or faintly present in 
inflamed tissue (B). Each section 
was counterstained with hema-
toxylin. Bar scale=50 µm. Original 
magnification=200X.
Table 2. S100 a4, a8, a9, and b poSiTiviTy in differenT SampleS of human healThy limbuS. 
Tissues S100 positivity S100 A4 positivity S100 A8 positivity S100 A9 positivity S100 B positivity
Healthy limbus 1 ++ + +/− ++ -
Healthy limbus 2 ++ + - ++ -
Healthy limbus 3 ++ ++ - ++ -
Healthy limbus 4 ++ ++ - ++ -
Healthy limbus 5 ++ ++ - ++ -
Healthy limbus 6 ++ ++ +/− ++ -
Healthy limbus 7 ++ ++ - ++ -
Healthy limbus 8 ++ ++ +/− ++ -
Healthy limbus 9 ++ ++ +/− ++ -
++: strong posititvity -/+: few positive cells -: no positive cells
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reported in the literature as playing a role in cellular growth 
and differentiation.
Recent studies linked S100 A4 to several diseases in 
addition to cancer, including kidney fibrosis [18-21], cirrhosis, 
pulmonary disease [22-24], cardiac hypertrophy and fibrosis 
[25-27], arthritis [28-31], and neuronal injuries [32-34]. The 
involvement of fibrotic and inflammatory processes was 
common to all these diseases, that is, processes greatly 
dependent on tissue remodeling, cell motility, and epithelial–
mesenchymal transition.
Hence, S100 A4 interacts with cytoskeletal proteins 
and enhances metastasis of several types of cancer cells. In 
addition, S100 A4 is secreted by unknown mechanisms. This 
paracrine secretion stimulates various cellular responses, 
including angiogenesis and neuronal growth [35].
S100 A8 and A9 are mainly expressed in granulocytes 
and epithelial cells [16]. Secreted S100 A8 and S100 A9 
proteins from the heterodimer are important members of 
damage-associated molecular proteins [36]. A study of a 
murine model of corneal neovascularization showed that S100 
A8 and S100 A9 were involved in the inflammatory process; 
in particular, they facilitated the growth of new vessels [37].
S100 B is expressed in astrocytes and oligodendrocytes. 
Its concentration in cerebrospinal fluid (CSF) or serum is 
considered a suitable surrogate marker for the diagnostic and 
prognostic assessment of neurodegeneration (for example, in 
Alzheimer disease and amyotrophic lateral sclerosis). S100 B 
is not only implicated in regulating intracellular processes but 
is also a secretory protein exhibiting cytokine-like activities, 
which mediate interactions among glial cells and between 
glial cells and neurons [38]. To the best of our knowledge, this 
study provides the first illustration of limbal modifications 
induced by inflammation.
Since a history of corneal disease, such as documented 
keratitis, almost always precedes a diagnosis of endophthal-
mitis of different etiology [39], we speculate that a condi-
tion of ocular surface inflammation affecting sclerocorneal 
limbus is associated with flogistic processes that involve 
the entire ocular bulb. Moreover, in our pathological cases, 
all patients who underwent bulbar evisceration presented a 
specific history of ocular and or systemic diseases, associated 
with clinical signs of chronic ocular surface inflammation 
involving sclerocorneal limbus as documented by the inflam-
matory infiltration shown with immunohistochemistry anal-
ysis. Our results are certainly influenced by the differences 
in the pathophysiology of infection and limbal inflammation 
among the five cases analyzed. Moreover, patients who 
develop endophthalmitis are always in treatment with topical 
and or systemic steroids and antibiotics and often affected 
Figure 2. Expression of S100 A4, 
A8, A9, and B in human healthy 
limbal stem cell niche. S100 A4 
and A9 positivity was evident in 
the entire limbal stem cell niche 
(A–C). In contrast, S100 A8 posi-
tivity was present in only a few 
cells in the middle area of the crypt 
(B). No positivity was achieved for 
S100 B staining (D). Each section 
was counterstained with hema-
toxylin. Bar scale=50 µm. Original 
magnification=200X.
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by systemic conditions associated with relative immune 
dysfunction [39-41]. These differences, which also concern 
our pathological cases, of course affect our results, by the way 
the minimal percentage of patients with endophthalmitis who 
undergo evisceration [39] make collecting samples difficult, 
and obtaining an homogeneous group for analysis is hard.
In our study, we observed strong cytoplasmic expres-
sion of the total S100 family in all LECs of healthy corneas, 
while only a few positive cells were observed in inflamed 
limbus. This may involve different considerations. First, the 
drastic reduction in S100 expression, highlighted in limbal 
inflammation, showed a different behavior of this family 
of proteins in limbal tissues compared to the other forms of 
ocular surface inflammation in which S100 overexpression 
was reported [6-14]. Furthermore, this consideration supports 
the hypothesis that S100 proteins represent a marker of limbal 
normality. Moreover, A4 and A9 presented higher limbal 
expression in our healthy samples (Figure 2).
These considerations confirm the results already 
reported in literature, indicating the role of S100 A4 and 
A9 in cell differentiation, regulation of growth, and cellular 
structure, processes observed in the sclerocorneal limbus 
[15]. In particular, S100 A4 overexpression in tumor cells 
suggests that this protein plays a role in the expression of 
the transformed phenotype [1] similarly to the processes 
that control corneal epithelial stem cells at the limbus LECs 
[15,38].
Poor S100 A8 expression and the absence of S100 B 
(Figure 2) could be explained by the fact that these proteins 
are probably involved in processes that are not primarily 
found at the limbus (for example, response to chemotactic 
factors and regulation kinase activity [1] for A4 or cellular 
learning and memory processes for S100 B [42]). Further 
examinations and an increase in the number of healthy and 
pathological samples would help confirm these findings and 
lead to better understanding of the function of S100 proteins 
and their role at the limbus. These preliminary results further 
elucidate how the sclerocorneal limbus holds features that 
make it completely different from the other elements that 
constitute the ocular surface, and a complex structure that 
has yet to be investigated and discovered.
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